Wohua Pharmaceutical

Wohua Pharmaceutical (沃华医药) is a Chinese brand in the traditional Chinese medicine (TCM) sector, associated with 中成药 — the prepared, standardized forms of Chinese medicine such as tablets, capsules, granules, pills and oral liquids. The brand is positioned within the consumer-health and pharmaceutical space, where TCM products are sold both through hospitals and pharmacies and, for some lines, as over-the-counter remedies. The evidence available for this dossier identifies Wohua as a TCM brand operating in the 中成药 category, comparable in category terms to other prepared-medicine traditions such as Japan's kampo. Its official web presence is at wohua.com.cn. The company is based in China and serves the domestic Chinese market. Because the supplied evidence is limited to a category description, this entry should be treated as a category-level brand record rather than a fully documented corporate history. Details such as founding year, founders, ownership structure, stock listing and specific product lines are not established by the available evidence and are therefore left unstated rather than guessed. What can be said with confidence is that Wohua belongs to the broad Chinese pharmaceutical and consumer-health landscape, where 中成药 brands combine traditional formulations with modern manufacturing and regulatory standards. Such brands typically maintain portfolios spanning therapeutic areas such as cardiovascular, respiratory, digestive and musculoskeletal health, and they market through a mix of hospital channels, retail pharmacies and, increasingly, online health platforms. For a complete dossier, further primary sources — the company's official website, annual reports if listed, and regulatory filings — would be needed to document its history, leadership, products and financial status.

The available evidence does not provide a dated corporate history for Wohua Pharmaceutical. What is documented is its category identity: a traditional Chinese medicine brand associated with 中成药, the prepared and standardized forms of Chinese medicine. This places Wohua within the broader Chinese pharmaceutical industry, where 中成药 manufacturers combine classical formulations with modern production and quality-control methods. Historically, the 中成药 category in China evolved from traditional apothecary preparations into industrialized pharmaceutical production during the twentieth century, with brands building portfolios of approved, branded medicines sold through hospitals and pharmacies. Brands in this space are often compared internationally to Japan's kampo preparations, which similarly industrialize traditional formulas. Without further primary sources, specific milestones such as founding date, product launches, ownership changes or listings cannot be stated. This section should be expanded when official company materials become available.

Traditional Chinese medicine brand in the 中成药 (prepared TCM medicine) category.

• 中成药 (prepared TCM medicines)

  Standardized traditional Chinese medicine products such as tablets, capsules, granules, pills and oral liquids.

• 2021-01-20

  Wohua Pharmaceutical reports 2020 annual results[2]沃华医药披露2020年年报finance.sina.com.cn

  Reported: 2021-01-20

  Wohua Pharmaceutical disclosed its 2020 annual report on the evening of January 20, reporting revenue of 1.006 billion yuan and net profit attributable to shareholders of 179 million yuan.

1. 1Wohua Pharmaceutical official websitewohua.com.cn
2. 2沃华医药披露2020年年报finance.sina.com.cn